These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

943 related articles for article (PubMed ID: 33276482)

  • 1. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
    Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota and Complications of Type-2 Diabetes.
    Iatcu CO; Steen A; Covasa M
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
    Wu J; Yang K; Fan H; Wei M; Xiong Q
    Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
    Zhou Z; Sun B; Yu D; Zhu C
    Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy.
    Fernandes R; Viana SD; Nunes S; Reis F
    Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1876-1897. PubMed ID: 30287404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
    Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
    Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications.
    Zhang L; Chu J; Hao W; Zhang J; Li H; Yang C; Yang J; Chen X; Wang H
    Mediators Inflamm; 2021; 2021():5110276. PubMed ID: 34447287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota: A new target for T2DM prevention and treatment.
    Liu L; Zhang J; Cheng Y; Zhu M; Xiao Z; Ruan G; Wei Y
    Front Endocrinol (Lausanne); 2022; 13():958218. PubMed ID: 36034447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
    Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
    Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
    Huda MN; Kim M; Bennett BJ
    Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
    Sircana A; Framarin L; Leone N; Berrutti M; Castellino F; Parente R; De Michieli F; Paschetta E; Musso G
    Curr Diab Rep; 2018 Sep; 18(10):98. PubMed ID: 30215149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the microbiome in the management of children with type 2 diabetes mellitus.
    Brar PC; Kohn B
    Curr Opin Pediatr; 2019 Aug; 31(4):524-530. PubMed ID: 31299021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease.
    Zaky A; Glastras SJ; Wong MYW; Pollock CA; Saad S
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions Between Gut Microbiota, Host, and Herbal Medicines: A Review of New Insights Into the Pathogenesis and Treatment of Type 2 Diabetes.
    Zheng Y; Gou X; Zhang L; Gao H; Wei Y; Yu X; Pang B; Tian J; Tong X; Li M
    Front Cell Infect Microbiol; 2020; 10():360. PubMed ID: 32766169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gut Microbial Endocrine Organ in Type 2 Diabetes.
    Massey W; Brown JM
    Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33373432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota and Metabolic Disorders: Advances in Therapeutic Interventions.
    Akash MSH; Fiayyaz F; Rehman K; Sabir S; Rasool MH
    Crit Rev Immunol; 2019; 39(4):223-237. PubMed ID: 32421966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin.
    Huo L; Li H; Zhu M; Liu Y; Ren L; Hu J; Wang X
    Front Endocrinol (Lausanne); 2023; 14():1257457. PubMed ID: 38075058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus.
    Sánchez-Quintero MJ; Delgado J; Medina-Vera D; Becerra-Muñoz VM; Queipo-Ortuño MI; Estévez M; Plaza-Andrades I; Rodríguez-Capitán J; Sánchez PL; Crespo-Leiro MG; Jiménez-Navarro MF; Pavón-Morón FJ
    Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Significance of Gut Microbiota in Diabetes Pathogenesis and Management-A Narrative Review.
    Młynarska E; Wasiak J; Gajewska A; Steć G; Jasińska J; Rysz J; Franczyk B
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary flaxseed oil rich in omega-3 suppresses severity of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in rats.
    Zhu L; Sha L; Li K; Wang Z; Wang T; Li Y; Liu P; Dong X; Dong Y; Zhang X; Wang H
    Lipids Health Dis; 2020 Feb; 19(1):20. PubMed ID: 32028957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.